Role of renin–angiotensin system inhibitors in retardation of progression of end-stage renal failure: a retrospective study

2015 ◽  
Vol 20 (4) ◽  
pp. 603-610 ◽  
Author(s):  
Tomoyuki Murakami ◽  
Tamio Iwamoto ◽  
Gen Yasuda ◽  
Michiko Taniguchi ◽  
Akira Fujiwara ◽  
...  
2004 ◽  
Vol 97 (1) ◽  
pp. p1-p8 ◽  
Author(s):  
Yeow-Kok Lau ◽  
Keng-Thye Woo ◽  
Hui-Lin Choong ◽  
Yi Zhao ◽  
Hui-Boon Tan ◽  
...  

2006 ◽  
Vol 60 (6) ◽  
pp. 734-739 ◽  
Author(s):  
Ana C Simões E Silva ◽  
José Silvério S Diniz ◽  
Regina M Pereira ◽  
Sérgio V Brant Pinheiro ◽  
Robson Augusto S Santos

2004 ◽  
Vol 97 (2) ◽  
pp. p37-p44 ◽  
Author(s):  
Dierk H. Endemann ◽  
Konrad Wolf ◽  
Carsten A. Boeger ◽  
Günter A.J. Riegger ◽  
Bernhard K. Krämer

2001 ◽  
Vol 21 (6) ◽  
pp. 580-592 ◽  
Author(s):  
Arnold Boonstra ◽  
Dick de Zeeuw ◽  
Paul E. de Jong ◽  
Gerjan Navis

2020 ◽  
Vol 27 (6) ◽  
pp. 520-528 ◽  
Author(s):  
Izabela Guimarães Barbosa ◽  
Giulia Campos Ferreira ◽  
Diomildo Ferreira Andrade Júnior ◽  
Cássio Rocha Januário ◽  
André Rolim Belisário ◽  
...  

Bipolar Disorder (BD) is a chronic a multifactorial psychiatric illness that affects mood, cognition, and functioning. BD is associated with several psychiatric conditions as well clinical comorbidities, particularly cardiovascular diseases. The neurobiology of BD is complex and multifactorial and several systems have been implicated. Considering that the Renin Angiotensin System (RAS) plays an important role in cardiovascular diseases and that recently evidence has suggested its role in psychiatric disorders, the aim of the present study is to summarize and to discuss recent findings related to the modulation of RAS components in BD. A systematic search of the literature using the electronic databases MEDLINE and LILACS was conducted through March 2019. The search terms were: “Bipolar Disorder”; “Renin Angiotensin System”; “Angiotensin 2”; “Angiotensin receptors”; “Angiotensin 1-7”; “ACE”; “ACE2”; “Mas Receptor”. We included original studies assessing RAS in BD patients. Two hundred twenty-two citations were initially retrieved. Eleven studies were included in our systematic review. In the majority of studies (6 of 8), the ACE insertion/deletion (I/D) polymorphism did not differ between BD patients and controls. BD patients presented higher plasma renin activity in comparison with controls. The studies evaluating the RAS molecules in BD are very scarce and heterogeneous. The literature suggests a potential role of RAS in BD. Further studies are necessary to investigate this relationship.


Sign in / Sign up

Export Citation Format

Share Document